All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional.
The SOT Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the SOT Hub cannot guarantee the accuracy of translated content. The SOT Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Solid Organ Transplantation Hub is an independent medical education platform, sponsored by Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View solid organ transplantation content recommended for you
Results from a retrospective cohort study, evaluating the impact of extended-criteria donor (ECD) use according to recipient urgency status on survival outcomes in 1,251 adult lung transplant recipients registered with the Korean Network for Organ Sharing (KONOS; 2010–2023), were published in the Journal of Korean Medical Science by Yeo et al. Patients were stratified into five urgency categories (status 0–4) based on predefined medical criteria. Status 0 was defined as hospitalization with mechanical ventilation (MV) and/or extracorporeal membrane oxygenation (ECMO).
Key data: Among recipients, 33.7% received ECD lungs and 66.3% received standard criteria donor (SCD) lungs. In multivariable Cox regression analysis, recipient age (hazard ratio [HR], 1.02; 95% confidence interval [CI], 1.01–1.03; p < 0.001), urgency status 0 (HR, 1.62; 95% CI, 1.30–2.01; p < 0.001), and ECD use (HR, 1.44; 95% CI, 1.17–1.77; p = 0.001) were independently associated with increased 1-year mortality. In subgroup analysis, ECD use was associated with higher mortality vs SCD use in urgency status 1–4 recipients (p < 0.001), but not status 0 recipients (p = 0.056). Among elderly (≥65 years) and younger (<65 years) recipients, ECD use was associated with higher mortality vs SCD use in status 1–4 (p = 0.001 and p = 0.014, respectively), but not in status 0 (p = 0.071 and p = 0.226, respectively).
Key learning: ECD use is associated with higher 1-year mortality in urgency status 1–4 recipients, irrespective of age. In status 0 recipients, this effect differs by age. These data highlight the importance of considering recipient urgency and age in donor lung selection.
References
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
Your opinion matters
What do you consider to be the single greatest barrier to increased use of ECP in SOT patients at your center?